LYEL - Lyell Immunopharma - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LYEL is currently covered by 1 analysts with an average price target of $20. This is a potential upside of $80 (67.22%) from yesterday's end of day stock price of $11.96.

Lyell Immunopharma's activity chart (see below) currently has 4 price targets and 8 ratings on display. The stock rating distribution of LYEL is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 66.17 days.

Highest price target for LYEL is $20, Lowest price target is $20, average price target is $20.

Most recent stock forecast was given by from HC WAINWRIGHT on 24-Nov-2025. First documented stock forecast 12-Jul-2021.

Best performing analysts who are covering LYEL - Lyell Immunopharma:

Matthew Harrison Salveen Richter Mitchell Kapoor Geoff Meacham Christopher Liu

Currently out of the existing stock ratings of LYEL, 1 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 19-Aug-2024

$20

$8.39 (72.27%)

$20

9 months 21 days ago
(24-Nov-2025)

2/4 (50%)

$-2.72 (-11.97%)

169

Buy Since 26-Sep-2025

$20

$0.33 (1.68%)

11 months 19 days ago
(26-Sep-2025)

1/1 (100%)

$7.17 (55.88%)

59

Sell Since 30-Oct-2024

$400

$380.33 (1933.55%)

1 years 10 months 15 days ago
(30-Oct-2024)

0/2 (0%)

$382.84 (2231.00%)

Hold Since 14-Nov-2022

$140

3 years 7 months 21 days ago
(24-Jan-2023)

0/2 (0%)

$46 (48.94%)

Hold Since 11-Nov-2022

$140

$120.33 (611.74%)

$600

3 years 10 months 3 days ago
(11-Nov-2022)

0/2 (0%)

$49.4 (54.53%)

Show more analysts

Please expand the browser size to see the chart

What is LYEL (Lyell Immunopharma) average time for price targets to be met?

On average it took 66 days for the stock forecasts to be reached, with an average price target met ratio of 33.33%.

Which analyst most recently updated their price target on LYEL (Lyell Immunopharma)?

Which analyst has the most public recommendations on LYEL (Lyell Immunopharma)?

has 0 price targets and 0 ratings on LYEL

Which analyst is the currently most bullish on LYEL (Lyell Immunopharma)?

Geoff Meacham with the highest potential upside of $380.33

Which analyst is the currently most reserved on LYEL (Lyell Immunopharma)?

Matthew Harrison with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?